Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease

Movement Disorders

Volumn 13, Issue 5, 1998, Pages 775-781

  Skalabrin, Elaine J ^a   Laws Jr , Edward R ^a   Bennett Jr , James P ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

L dopa; Parkinson's disease; Pharmacodynamics; Stereotactic pallidotomy

Indexed keywords

LEVODOPA; PROLACTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DYSKINESIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMB MOVEMENT; MALE; MOTOR PERFORMANCE; ORAL DRUG ADMINISTRATION; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; STEREOTAXIC SURGERY; WALKING SPEED;

ADMINISTRATION, ORAL; AGED; ANTIPARKINSON AGENTS; COMBINED MODALITY THERAPY; DIHYDROXYPHENYLALANINE; DOMINANCE, CEREBRAL; FEMALE; GAIT; GLOBUS PALLIDUS; HUMANS; INFUSIONS, INTRAVENOUS; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROLACTIN; STEREOTAXIC TECHNIQUES;

EID: 0031656908     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130504     Document Type: Article

References (21)

1. Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Neurol Scand 1960;35:358-377.
2. Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 1992;58:14-21.
3. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
4. Laitinen LV. Pallidotomy for Parkinson's disease. Functional Neurosurgery 1995;6:105-112.
5. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
6. Iacono RP, Shima F, Lonser RR, et al. The results, indications and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 1995:36:1125-1127.
7. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of Gpi pallidotomy on motor function in Parkinson's disease. Lancet 1995:346:1383-1387.
8. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior Gpi pallidotomy: 1-year results of a pilot study. Ann Neural 1995:40:355-366.
9. Uitti RJ, Wharen RE Jr, Turk MF, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997;49:1072-1077.
10. Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
11. Kopyov O, Jacques D, Duma C, et al. Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease. J Neurosurg 1997;87:52-59.
12. Kishore A, Turnbull IM, Snow BJ, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Sixmonth follow-up with additional 1-year observations. Brain 1997;120:729-737.
13. Johansson F, Malm J, Nordh E, Hariz M. Usefulness of pal-lidotomy in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:125-132.
14. Ondo WG, Jankovic J, Lai EC, et al. Assessment of motor function after stereotactic pallidotomy. Neurology 1998;50:266-270.
15. Giller CA, Dewey RB, Ginsburg MI, et al. Stereotactic pallidotomy and thalamotomy using individual variations of anatomic landmarks for localization. Neurosurgery 1998;42:55-62.
16. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res 1990;85:119-146.
17. Parent A, Hazrati LN. Functional anatomy of the basal ganglia I. T corticobasal ganglia-thalamo-cortical loop. Brain Res Rev 1995;20:91-127.
18. Lawton N, MacDermot J. Abnormal regulation of prolactin release in idiopathic Parkinson's disease. J Neural Neurosurg Psychiatry 1980;43:1012-1015.
19. Laihinen A, Rinne K. Function of levodopamine receptors in Parkinson's disease: prolactin response. Neurology 1986;36:393-395.
20. Eisler T, Thorner MO, MacLeod RM, et al. Prolactin secretion in Parkinson's disease. Neurology 1981;31:1356-1359.
21. Kostic VS, Marinkovic Z, Filipovic S, Momcilovic D. Function of levodopamine receptors in young-onset Parkinson's disease: prolactin response. Mov Disord 1993;8:227-229.